JANNEL PICHARDO: Open Payments
NPI 1013272244 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,305 in 95 payments from 21 companies in 2025. Trend: 2023 $1,874 · 2024 $2,498 · 2025 $2,305
Food & beverage: $2,262Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $368 |
| Novartis Pharmaceuticals Corporation | 10 | $267 |
| Arcutis Biotherapeutics, Inc. | 13 | $251 |
| REVANCE THERAPEUTICS, INC. | 2 | $171 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $153 |
| E.R. Squibb & Sons, L.L.C. | 6 | $146 |
| Lilly USA, LLC | 6 | $128 |
| GENZYME CORPORATION | 4 | $109 |
| Incyte Corporation | 5 | $107 |
| LEO Pharma Inc. | 6 | $96 |
Products named: Zoryve, DUPIXENT, DAXXIFY, COSENTYX, BOTOX, Winlevi, Sotyktu, RINVOQ.
Industry payments across FL — which companies pay providers there.
